JASON GRIFFIN: Open Payments
NPI 1063485068 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 8 payments from 6 companies in 2025. Trend: 2023 $103 · 2024 $101 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Dexcom, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: Ozempic, TRELEGY ELLIPTA, Dexcom G6 Transmitter, Veozah, VYNDAQEL, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
